Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review
Ziwen Tao, Baoquan Cheng, Tao Zhou, et al.
Hepatobiliary & pancreatic diseases international (2021) Vol. 21, Iss. 2, pp. 134-144
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150
Richard S. Finn, Peter R. Galle, Michel Ducreux, et al.
Liver Cancer (2024), pp. 1-14
Open Access | Times Cited: 6
The Treatment of Hepatocellular Carcinoma with Major Vascular Invasion
Tomoko Tadokoro, Joji Tani, Asahiro Morishita, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2534-2534
Open Access | Times Cited: 6
Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study
Xiaoquan Ji, Zhe Xu, Jing Sun, et al.
Radiation Oncology (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 13
Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis
Yu-Chun Hsu, Po‐Ting Lin, Wei Teng, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3458-3458
Open Access | Times Cited: 4
Efficacy and safety of pembrolizumab in the treatment of advanced hepatocellular carcinoma: a systematic review and meta-analysis
Mingyang Tang, Tao Liu, Yukun Zhang, et al.
European Journal of Clinical Pharmacology (2025)
Closed Access
Efficacy and safety comparison between Lenvatinib and Sorafenib in hepatocellular carcinoma treatment: a systematic review and meta-analysis of real-world study
Xuefeng Hua, Zi‐Wei Yin, Jin Liang, et al.
European Journal of Gastroenterology & Hepatology (2023) Vol. 36, Iss. 1, pp. 120-128
Open Access | Times Cited: 9
HAIC versus TACE for patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis
Liu Jun-guo, Jinjuan Zhang, Yijun Wang, et al.
Medicine (2022) Vol. 101, Iss. 51, pp. e32390-e32390
Open Access | Times Cited: 14
Clinical application of spectral CT perfusion scanning in evaluating the blood supply source of portal vein tumor thrombus in hepatocellular carcinoma
Chunhan Pan, Feng Dai, Liuli Sheng, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 2
Anti-PD-1/L1 antibody plus anti-VEGF antibody vs. plus VEGFR-targeted TKI as first-line therapy for unresectable hepatocellular carcinoma: a network meta-analysis
Yiwen Zhou, Jingjing Li, Jieer Ying
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 3, pp. 568-580
Open Access | Times Cited: 2
The heterogeneity of cellular metabolism in the tumour microenvironment of hepatocellular carcinoma with portal vein tumour thrombus
Xiuping Zhang, W. X. Zou, Zhen‐Qi Li, et al.
Cell Proliferation (2024)
Open Access | Times Cited: 2
Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis
Long-Wang Lin, Leye Yan, Kun Ke, et al.
Brachytherapy (2023) Vol. 22, Iss. 6, pp. 858-871
Closed Access | Times Cited: 6
The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function
Hideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4873-4873
Open Access | Times Cited: 7
Efficacy and safety analysis of TACE + PEI + lenvatinib compared with TACE + lenvatinib for the treatment of hepatocellular carcinoma with PVTT: a retrospective study
Haohao Lu, Chuansheng Zheng, Bin Liang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Current Trends in Hepatocellular Carcinoma Therapies in China
Ying Zhang, Yong Wang, Jin‐He Guo, et al.
Digestive Disease Interventions (2024) Vol. 08, Iss. 03, pp. 173-182
Closed Access | Times Cited: 1
Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma
Tongguo Miao, Shiya Zhang, Yunjing Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review)
Ganghui Ye, Meng Ye, Xin Jin
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4113-4171
Closed Access | Times Cited: 1
Stereotactic body radiotherapy versus lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity matching score analysis
Xiaoquan Ji, Aimin Zhang, Xuezhang Duan, et al.
Radiation Oncology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Comparison of various liver cancer staging systems in predicting prognosis after initial transcatheter arterial chemoembolization: a retrospective study from China
Bin Lan, Chao Luo, Christine Pocha, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 6, pp. 2599-2612
Open Access | Times Cited: 1
Case Report: Radiotherapy Plus Immunotherapy and Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma With a Right Atrium and Inferior Vena Cava Tumor Thrombus
Yuting Qian, Long Gong, Li Su, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Imaging findings of hepatocellular carcinoma with portal vein tumor thrombosis secondary to hepatic portal vein collateral circulation: a cross-sectional study
Bo Shi, Cheng Bian, Zhigang Li, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 1, pp. 334-351
Open Access | Times Cited: 2
Survival benefit of perioperative locoregional adjuvant treatment for hepatocellular carcinoma with portal vein tumor thrombosis: A systematic review and Bayesian network meta-analysis
Hao Sun, Bing Ma, Ning Sun, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 189, pp. 104083-104083
Closed Access | Times Cited: 1
Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertension
Jiyao Sheng, Zifan Meng, Qiao Li, et al.
Hepatobiliary & pancreatic diseases international (2023) Vol. 23, Iss. 1, pp. 4-13
Closed Access | Times Cited: 1
The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts
Massimiliano Cadamuro, Giorgia Nuozzi, Paolo Simioni, et al.
Hepatoma Research (2023)
Open Access | Times Cited: 1
Combined DeRitis ratio and alkaline phosphatase on the Prediction of Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma
Tongguo Miao, Shiya Zhang, Yunjing Zhang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Combined Deritis Ratio And Alkaline Phosphatase on the Prediction Of Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma
Tongguo Miao, Shiya Zhang, Y. Zhang, et al.
(2024)
Open Access
Page 1 - Next Page

Scroll to top